These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 23759676)

  • 1. Cyclophosphamide induces a type I interferon-associated sterile inflammatory response signature in cancer patients' blood cells: implications for cancer chemoimmunotherapy.
    Moschella F; Torelli GF; Valentini M; Urbani F; Buccione C; Petrucci MT; Natalino F; Belardelli F; Foà R; Proietti E
    Clin Cancer Res; 2013 Aug; 19(15):4249-61. PubMed ID: 23759676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unraveling cancer chemoimmunotherapy mechanisms by gene and protein expression profiling of responses to cyclophosphamide.
    Moschella F; Valentini M; Aricò E; Macchia I; Sestili P; D'Urso MT; Alessandri C; Belardelli F; Proietti E
    Cancer Res; 2011 May; 71(10):3528-39. PubMed ID: 21444678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration.
    Bracci L; Moschella F; Sestili P; La Sorsa V; Valentini M; Canini I; Baccarini S; Maccari S; Ramoni C; Belardelli F; Proietti E
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):644-53. PubMed ID: 17255288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-gamma induces apoptosis and expression of inflammation-related proteins in Chang conjunctival cells.
    De Saint Jean M; Brignole F; Feldmann G; Goguel A; Baudouin C
    Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2199-212. PubMed ID: 10476784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phthalates suppress type I interferon in human plasmacytoid dendritic cells via epigenetic regulation.
    Kuo CH; Hsieh CC; Kuo HF; Huang MY; Yang SN; Chen LC; Huang SK; Hung CH
    Allergy; 2013 Jul; 68(7):870-9. PubMed ID: 23738920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human monocyte-derived dendritic cells pulsed with wild-type p53 protein efficiently induce CTLs against p53 overexpressing human cancer cells.
    Tokunaga N; Murakami T; Endo Y; Nishizaki M; Kagawa S; Tanaka N; Fujiwara T
    Clin Cancer Res; 2005 Feb; 11(3):1312-8. PubMed ID: 15709203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclophosphamide induces type I interferon and augments the number of CD44(hi) T lymphocytes in mice: implications for strategies of chemoimmunotherapy of cancer.
    Schiavoni G; Mattei F; Di Pucchio T; Santini SM; Bracci L; Belardelli F; Proietti E
    Blood; 2000 Mar; 95(6):2024-30. PubMed ID: 10706870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of interferon-stimulated genes by gamma-ray irradiation independently of the ataxia telangiectasia mutated-p53 pathway.
    Sugihara T; Murano H; Nakamura M; Ichinohe K; Tanaka K
    Mol Cancer Res; 2011 Apr; 9(4):476-84. PubMed ID: 21357441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cells fused with allogeneic colorectal cancer cell line present multiple colorectal cancer-specific antigens and induce antitumor immunity against autologous tumor cells.
    Koido S; Hara E; Homma S; Torii A; Toyama Y; Kawahara H; Watanabe M; Yanaga K; Fujise K; Tajiri H; Gong J; Toda G
    Clin Cancer Res; 2005 Nov; 11(21):7891-900. PubMed ID: 16278414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiling in Paget's disease of bone: upregulation of interferon signaling pathways in pagetic monocytes and lymphocytes.
    Nagy ZB; Gergely P; Donáth J; Borgulya G; Csanád M; Poór G
    J Bone Miner Res; 2008 Feb; 23(2):253-9. PubMed ID: 18197754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
    Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divergent effect of cobalt and beryllium salts on the fate of peripheral blood monocytes and T lymphocytes.
    Paladini F; Cocco E; Potolicchio I; Fazekasova H; Lombardi G; Fiorillo MT; Sorrentino R
    Toxicol Sci; 2011 Feb; 119(2):257-69. PubMed ID: 20974702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining the ability of cyclophosphamide preconditioning to enhance the antigen-specific CD8+ T-cell response to peptide vaccination: creation of a beneficial host microenvironment involving type I IFNs and myeloid cells.
    Salem ML; Kadima AN; El-Naggar SA; Rubinstein MP; Chen Y; Gillanders WE; Cole DJ
    J Immunother; 2007 Jan; 30(1):40-53. PubMed ID: 17198082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiparametric flow cytometric analysis of signal transducer and activator of transcription 5 phosphorylation in immune cell subsets in vitro and following interleukin-2 immunotherapy.
    Varker KA; Kondadasula SV; Go MR; Lesinski GB; Ghosh-Berkebile R; Lehman A; Monk JP; Olencki T; Kendra K; Carson WE
    Clin Cancer Res; 2006 Oct; 12(19):5850-8. PubMed ID: 17020993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.
    Ozer H; Gavigan M; O'Malley J; Thompson D; Dadey B; Nussbaum-Blumenson A; Snider C; Rudnick S; Ferraresi R; Norred S
    J Biol Response Mod; 1983; 2(6):499-515. PubMed ID: 6607323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-4 decreases the expression of the monocyte differentiation marker CD14, paralleled by an increasing accessory potency.
    Ruppert J; Friedrichs D; Xu H; Peters JH
    Immunobiology; 1991 Aug; 182(5):449-64. PubMed ID: 1717365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.
    Geppert TD; Lipsky PE
    J Immunol; 1985 Dec; 135(6):3750-62. PubMed ID: 3934267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-gamma and B-cell Activating Factor (BAFF) promote bovine B cell activation independent of TLR9 and T-cell signaling.
    Buchanan R; Popowych Y; Dagenais C; Arsic N; Mutwiri GK; Potter AA; Babiuk LA; Griebel PJ; Wilson HL
    Vet Immunol Immunopathol; 2012 Jan; 145(1-2):453-63. PubMed ID: 22264737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uncarinic acid C plus IFN-γ generates monocyte-derived dendritic cells and induces a potent Th1 polarization with capacity to migrate.
    Bae WK; Umeyama A; Chung IJ; Lee JJ; Takei M
    Cell Immunol; 2010; 266(1):104-10. PubMed ID: 20933226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.